# Deep Adaptive Model-Based Design of Experiments

arXiv: https://arxiv.org/abs/2603.16146 · HTML: https://mlsanity.com/paper/2603.16146/

## Key facts

- Cited by 1 papers in the map (data through 14 Oct 2026).
- Builds on 6 of its 16 references that are in the map.
- First posted on arXiv 17 Mar 2026.

## Builds on (most cited first, 6 of 6)

- [Attention Is All You Need](https://mlsanity.com/paper/1706.03762/) (2017)
- [Universal Differential Equations for Scientific Machine Learning](https://mlsanity.com/paper/2001.04385/) (2020)
- [Deep Adaptive Design: Amortizing Sequential Bayesian Experimental Design](https://mlsanity.com/paper/2103.02438/) (2021)
- [On Nesting Monte Carlo Estimators](https://mlsanity.com/paper/1709.06181/) (2017)
- [Implicit Deep Adaptive Design: Policy-Based Experimental Design without Likelihoods](https://mlsanity.com/paper/2111.02329/) (2021)
- [Instead of Rewriting Foreign Code for Machine Learning, Automatically Synthesize Fast Gradients](https://mlsanity.com/paper/2010.01709/) (2020)

## Built on by (most cited first, 1 of 1)

- [Deep Adaptive Bayesian Screening](https://mlsanity.com/paper/2607.16927/) (2026)

## Abstract (arXiv)

Model-based design of experiments (MBDOE) is essential for efficient parameter estimation in nonlinear dynamical systems. However, conventional adaptive MBDOE requires costly posterior inference and design optimization between each experimental step, precluding real-time applications. We address this by combining Deep Adaptive Design (DAD), which amortizes sequential design into a neural network policy trained offline, with differentiable mechanistic models. For dynamical systems with known governing equations but uncertain parameters, we extend sequential contrastive training objectives to handle nuisance parameters and propose a transformer-based policy architecture that respects the temporal structure of dynamical systems. We demonstrate the approach on four systems of increasing complexity: a fed-batch bioreactor with Monod kinetics, a Haldane bioreactor with uncertain substrate inhibition, a two-compartment pharmacokinetic model with nuisance clearance parameters, and a DC motor for real-time deployment.
